UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2008-08, Vol.105 (34), p.12182-12187

2008

Volltextzugriff (PDF)

Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity

International journal of molecular sciences, 2022-03, Vol.23 (6), p.2904

2022

Volltextzugriff (PDF)

Vitamin E Succinate Inhibits the Function of Androgen Receptor and the Expression of Prostate-Specific Antigen in Prostate Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 2002-05, Vol.99 (11), p.7408-7413

2002

Volltextzugriff (PDF)

Activation of Ras/Erk Pathway by a Novel MET-interacting Protein RanBPM

The Journal of biological chemistry, 2002-09, Vol.277 (39), p.36216-36222

2002

Volltextzugriff (PDF)

Ubiquitination of a Novel Deubiquitinating Enzyme Requires Direct Binding to von Hippel-Lindau Tumor Suppressor Protein

The Journal of biological chemistry, 2002-02, Vol.277 (7), p.4656-4662

2002

Volltextzugriff (PDF)

Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (21), p.9807-9816

2005

Volltextzugriff (PDF)

Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel–Lindau tumor suppressor

Biochemical and biophysical research communications, 2002-06, Vol.294 (3), p.700-709

2002

Volltextzugriff (PDF)

Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1

BMC urology, 2008-04, Vol.8 (1), p.7-7, Article 7

2008

Volltextzugriff (PDF)

Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals

JNCI : Journal of the National Cancer Institute, 2007-04, Vol.99 (7), p.558-568

2007

Volltextzugriff (PDF)

Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3

Carcinogenesis (New York), 2014-06, Vol.35 (6), p.1301-1309

2014

Volltextzugriff (PDF)

E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis

Oncotarget, 2014-12, Vol.5 (23), p.12097-12110

2014

Volltextzugriff (PDF)

Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer

Oncotarget, 2016-05, Vol.7 (19), p.27325-27335

2016

Volltextzugriff (PDF)

Androgen deprivation therapy for prostate cancer

Expert opinion on pharmacotherapy, 2008-02, Vol.9 (2), p.211-228

2008

Volltextzugriff (PDF)

AUTOMATED NONINVASIVE MEASUREMENT OF CYCLOPHOSPHAMIDE-INDUCED CHANGES IN MURINE VOIDING FREQUENCY AND VOLUME

The Journal of urology, 2001-02, Vol.165 (2), p.653-659

2001

Volltextzugriff (PDF)

Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney

Journal of biomedical optics, 2012-09, Vol.17 (9), p.98002-98001

2012

Volltextzugriff (PDF)

Decreased Bladder Cancer Growth in Parous Mice

Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.470-473

2008

Volltextzugriff (PDF)

Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: Potential therapeutic approaches for prostate cancer

Molecular carcinogenesis, 2005-09, Vol.44 (1), p.1-10

2005

Volltextzugriff (PDF)

DBCCR1 mediates death in cultured bladder tumor cells

Oncogene, 2004-01, Vol.23 (1), p.82-90

2004

Volltextzugriff (PDF)

Initial observations of reduced uroflow in transgenic adenocarcinoma of murine prostate

Urology (Ridgewood, N.J.), 2006-06, Vol.67 (6), p.1324-1328

2006

Volltextzugriff (PDF)

Early detection and measurement of urothelial tumors in mice

Urology (Ridgewood, N.J.), 2006-06, Vol.67 (6), p.1309-1314

2006

Volltextzugriff (PDF)

Increased Expression of the Acid Sphingomyelinase-Like Protein ASML3a in Bladder Tumors

The Journal of urology, 2002-12, Vol.168 (6), p.2645-2649

2002

Volltextzugriff (PDF)

Continuous bladder infusion methods for studying voiding function in the ambulatory mouse

Urology (Ridgewood, N.J.), 2002-10, Vol.60 (4), p.707-713

2002

Volltextzugriff (PDF)

Uroflow in murine urethritis

Urology (Ridgewood, N.J.), 2004-08, Vol.64 (2), p.378-382

2004

Volltextzugriff (PDF)

Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors

The Prostate, 2002-05, Vol.51 (3), p.153-165

2002

Volltextzugriff (PDF)

Effect of angiotensin converting enzyme inhibition on the Doppler waveform in dogs with renal artery stenosis

Journal of ultrasound in medicine, 1999-07, Vol.18 (7), p.481-487

1999

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity

Vitamin E Succinate Inhibits the Function of Androgen Receptor and the Expression of Prostate-Specific Antigen in Prostate Cancer Cells

Activation of Ras/Erk Pathway by a Novel MET-interacting Protein RanBPM

Ubiquitination of a Novel Deubiquitinating Enzyme Requires Direct Binding to von Hippel-Lindau Tumor Suppressor Protein

Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway

Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel–Lindau tumor suppressor

Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1

Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals

Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3

E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis

Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer

Androgen deprivation therapy for prostate cancer

AUTOMATED NONINVASIVE MEASUREMENT OF CYCLOPHOSPHAMIDE-INDUCED CHANGES IN MURINE VOIDING FREQUENCY AND VOLUME

Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney

Decreased Bladder Cancer Growth in Parous Mice

Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: Potential therapeutic approaches for prostate cancer

DBCCR1 mediates death in cultured bladder tumor cells

Initial observations of reduced uroflow in transgenic adenocarcinoma of murine prostate

Early detection and measurement of urothelial tumors in mice

Increased Expression of the Acid Sphingomyelinase-Like Protein ASML3a in Bladder Tumors

Continuous bladder infusion methods for studying voiding function in the ambulatory mouse

Uroflow in murine urethritis

Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors

Effect of angiotensin converting enzyme inhibition on the Doppler waveform in dogs with renal artery stenosis

Aktive Filter

Suchergebnisse filtern